Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Garry J. Douglas"'
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Figure 1-2. Supplemental Figure 1: Pharmacology of POL5551; Supplemental Figure 2: Correlation of CXCR4 expression in primary tumor with survival in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35bdd674a20e9eff353c1fd084861560
https://doi.org/10.1158/1535-7163.22507255.v1
https://doi.org/10.1158/1535-7163.22507255.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Figure 5. Eribulin dose ranging study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cea9ef473838bff804e8ac90d64e2bd
https://doi.org/10.1158/1535-7163.22507246.v1
https://doi.org/10.1158/1535-7163.22507246.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Figure 3. Gaussia luciferase complementation imaging model and scratch migration assay with AMD3100.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302a4c36bf35925a1c265d0af7bfef62
https://doi.org/10.1158/1535-7163.22507252.v1
https://doi.org/10.1158/1535-7163.22507252.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Figure 4. MDA-MB-231 primary tumor weight and liver metastases data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18264d11afd52e2afa1cde8936b1c0a5
https://doi.org/10.1158/1535-7163.22507249.v1
https://doi.org/10.1158/1535-7163.22507249.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Figure 6. Mobilization of leukocytes with POL5551.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edc0dcdb3da42c13078ab7e611c2769
https://doi.org/10.1158/1535-7163.22507243.v1
https://doi.org/10.1158/1535-7163.22507243.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
The SDF-1 receptor CXCR4 has been associated with early metastasis and poorer prognosis in breast cancers, especially the most aggressive triple-negative subtype. In line with previous reports, we found that tumoral CXCR4 expression in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e886f21b8f1e147cfa472cecea30d1f
https://doi.org/10.1158/1535-7163.c.6538633.v1
https://doi.org/10.1158/1535-7163.c.6538633.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Table 1-3. Pharmacology of POL5551 and patient characteristics at baseline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a756d8ae94a02d86f947a193953b16b
https://doi.org/10.1158/1535-7163.22507237.v1
https://doi.org/10.1158/1535-7163.22507237.v1
Autor:
Katherine N. Weilbaecher, Klaus Dembowsky, Rebecca L. Aft, Johann Zimmermann, Michael Bauer, Gary D. Luker, Eric Chevalier, Gérald Tuffin, Barbara Romagnoli, Foluso O. Ademuyiwa, Timothy Pluard, Kathryn E. Luker, Chidananda Mudalagiriyappa, Garry J. Douglas, Alison K. Esser, Sarah R. Amend, Xinming Su, Francesca Fontana, Michelle A. Hurchla, Jingyu Xiang
Supplemental Figure 7. Effect of POL5551 combined with eribulin on hematopoietic cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6df3d9585283f35cd11414a910f351
https://doi.org/10.1158/1535-7163.22507240
https://doi.org/10.1158/1535-7163.22507240
Publikováno v:
Immunity, Inflammation and Disease
Introduction Asthma is major health burden throughout the world, and there are no therapies that have been shown to be able to prevent the development of disease. A severe respiratory paramyxoviral infection early in life has been demonstrated to gre
Autor:
Sasha Sreckovic, Roddy Walsh, David J. Lamb, Kristina Ulrich, Michael Yeadon, Jennifer S. Hincks, Steven Evans, Christelle Perros-Huguet, Mark Fidock, Garry J. Douglas, E.M. Caroline Wetterstrand
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 21:637-647
Asthma affects 300 million people worldwide and continues to be a major cause of morbidity and mortality. Disease relevant animal models of asthma are required for benchmarking of novel therapeutic mechanisms in comparison to established clinical app